Nebulized inhalation of plasma-activated water in the treatment of progressive moderate COVID-19 patients with antiviral treatment failure: a randomized controlled pilot trial

{ 'indexed': {'date-parts': [[2024, 9, 13]], 'date-time': '2024-09-13T00:48:09Z', 'timestamp': 1726188489039}, 'reference-count': 49, 'publisher': 'Springer Science and Business Media LLC', 'issue': '1', 'license': [ { 'start': { 'date-parts': [[2024, 9, 12]], 'date-time': '2024-09-12T00:00:00Z', 'timestamp': 1726099200000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by-nc-nd/4.0'}, { 'start': { 'date-parts': [[2024, 9, 12]], 'date-time': '2024-09-12T00:00:00Z', 'timestamp': 1726099200000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by-nc-nd/4.0'}], 'funder': [ { 'name': 'The Key projects of basic research of natural science in Shaanxi Province', 'award': ['No. 2022JZ-58']}, {'name': 'The Discipline Promotion Plan of Xijing Hospital', 'award': ['No. XJZT21CZ06']}, { 'name': 'The Clinical Research Program of Air Force Military Medical University', 'award': ['No. 2021JSTS36']}, { 'name': 'The Shaanxi Provincial Health Scientific Research Fund Project', 'award': ['No. 2021A006']}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'DOI': '10.1186/s12879-024-09886-w', 'type': 'journal-article', 'created': {'date-parts': [[2024, 9, 12]], 'date-time': '2024-09-12T09:05:01Z', 'timestamp': 1726131901000}, 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Nebulized inhalation of plasma-activated water in the treatment of progressive moderate COVID-19 ' 'patients with antiviral treatment failure: a randomized controlled pilot trial', 'prefix': '10.1186', 'volume': '24', 'author': [ {'given': 'Heng', 'family': 'Zhao', 'sequence': 'first', 'affiliation': []}, {'given': 'Wanting', 'family': 'Meng', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xing', 'family': 'Lv', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jing', 'family': 'Li', 'sequence': 'additional', 'affiliation': []}, {'given': 'Zhigui', 'family': 'Cai', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xingxing', 'family': 'Guo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Zifeng', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Li', 'family': 'Guo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mingzhe', 'family': 'Rong', 'sequence': 'additional', 'affiliation': []}, {'given': 'Cong', 'family': 'Shen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dingxin', 'family': 'Liu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Liqiang', 'family': 'Song', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2024, 9, 12]]}, 'reference': [ { 'issue': '5', 'key': '9886_CR1', 'doi-asserted-by': 'publisher', 'first-page': '961', 'DOI': '10.3390/v14050961', 'volume': '14', 'author': 'TI Ng', 'year': '2022', 'unstructured': 'Ng TI, Correia I, Seagal J, DeGoey DA, Schrimpf MR, Hardee DJ, Noey EL, ' 'Kati WM. Antiviral drug discovery for the treatment of COVID-19 ' 'infections. Viruses-Basel. 2022;14(5):961.', 'journal-title': 'VIRUSES-BASEL'}, { 'key': '9886_CR2', 'doi-asserted-by': 'crossref', 'unstructured': 'Owen DR, Allerton CMN, Anderson AS, Aschenbrenner L, Avery M, Berritt S, ' 'Boras B, Cardin RD, Carlo A, Coffman KJ et al. An oral SARS-CoV-2 Mpro ' 'inhibitor clinical candidate for the treatment of COVID-19. Science. ' '2021;374(6575):1586–1593.', 'DOI': '10.1126/science.abl4784'}, { 'issue': '9', 'key': '9886_CR3', 'doi-asserted-by': 'publisher', 'first-page': '740', 'DOI': '10.1038/s41594-021-00651-0', 'volume': '28', 'author': 'F Kabinger', 'year': '2021', 'unstructured': 'Kabinger F, Stiller C, Schmitzová J, Dienemann C, Kokic G, Hillen HS, ' 'Höbartner C, Cramer P. Mechanism of molnupiravir-induced SARS-CoV-2 ' 'mutagenesis. Nat Struct Mol Biol. 2021;28(9):740–6.', 'journal-title': 'NAT STRUCT MOL BIOL'}, { 'issue': '15', 'key': '9886_CR4', 'doi-asserted-by': 'publisher', 'first-page': '1397', 'DOI': '10.1056/NEJMoa2118542', 'volume': '386', 'author': 'J Hammond', 'year': '2022', 'unstructured': 'Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, ' 'Baniecki M, Hendrick VM, Damle B, Simón-Campos A, et al. Oral ' 'nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. New ' 'Engl J Med. 2022;386(15):1397–408.', 'journal-title': 'NEW ENGL J MED'}, { 'issue': '6', 'key': '9886_CR5', 'doi-asserted-by': 'publisher', 'first-page': '509', 'DOI': '10.1056/NEJMoa2116044', 'volume': '386', 'author': 'A Jayk Bernal', 'year': '2022', 'unstructured': 'Jayk Bernal A, Gomes Da Silva MM, Musungaie DB, Kovalchuk E, Gonzalez A, ' 'Delos Reyes V, Martín-Quirós A, Caraco Y, Williams-Diaz A, Brown ML, et ' 'al. Molnupiravir for oral treatment of Covid-19 in nonhospitalized ' 'patients. New Engl J Med. 2022;386(6):509–20.', 'journal-title': 'NEW ENGL J MED'}, { 'key': '9886_CR6', 'doi-asserted-by': 'publisher', 'first-page': '100602', 'DOI': '10.1016/j.lanwpc.2022.100602', 'volume': '30', 'author': 'AK Wai', 'year': '2023', 'unstructured': 'Wai AK, Chan CY, Cheung AW, Wang K, Chan SC, Lee TT, Luk LY, Yip ET, Ho ' 'JW, Tsui OW, et al. Association of Molnupiravir and ' 'Nirmatrelvir-Ritonavir with preventable mortality, hospital admissions ' 'and related avoidable healthcare system cost among high-risk patients ' 'with mild to moderate COVID-19. Lancet Reg Health - Western Pac. ' '2023;30:100602.', 'journal-title': 'Lancet Reg Health - Western Pac'}, { 'issue': '9', 'key': '9886_CR7', 'doi-asserted-by': 'publisher', 'first-page': '2830', 'DOI': '10.1111/bcp.15783', 'volume': '89', 'author': 'W Zhuang', 'year': '2023', 'unstructured': 'Zhuang W, Xu J, Wu Y, Yang J, Lin X, Liao Y, Wan J, Weng L, Lin W. ' 'Post-marketing safety concerns with nirmatrelvir: a disproportionality ' 'analysis of spontaneous reports submitted to the FDA adverse event ' 'reporting system. Brit J Clin Pharmaco. 2023;89(9):2830–42.', 'journal-title': 'BRIT J CLIN PHARMACO'}, { 'issue': '1', 'key': '9886_CR8', 'doi-asserted-by': 'publisher', 'first-page': '34', 'DOI': '10.3390/jcm12010034', 'volume': '12', 'author': 'G Santi Laurini', 'year': '2023', 'unstructured': 'Santi Laurini G, Montanaro N, Motola D. Safety profile of Molnupiravir ' 'in the treatment of COVID-19: a descriptive study based on FAERS data. J ' 'Clin Med. 2023;12(1):34.', 'journal-title': 'J CLIN MED'}, { 'issue': '1', 'key': '9886_CR9', 'doi-asserted-by': 'publisher', 'first-page': '39', 'DOI': '10.1515/hsz-2018-0226', 'volume': '400', 'author': 'NK Kaushik', 'year': '2019', 'unstructured': 'Kaushik NK, Ghimire B, Li Y, Adhikari M, Veerana M, Kaushik N, Jha N, ' 'Adhikari B, Lee S, Masur K, et al. Biological and medical applications ' 'of plasma-activated media, water and solutions. Biol Chem. ' '2019;400(1):39.', 'journal-title': 'BIOL CHEM'}, { 'key': '9886_CR10', 'doi-asserted-by': 'crossref', 'unstructured': 'Kim S, Kim C. Applications of plasma-activated liquid in the medical ' 'field. Biomedicines. 2021;9(11):1700.', 'DOI': '10.3390/biomedicines9111700'}, { 'issue': '30', 'key': '9886_CR11', 'doi-asserted-by': 'publisher', 'first-page': '303001', 'DOI': '10.1088/1361-6463/ab81cf', 'volume': '53', 'author': 'R Zhou', 'year': '2020', 'unstructured': 'Zhou R, Zhou R, Wang P, Xian Y, Mai-Prochnow A, Lu X, Cullen PJ, ' 'Ostrikov KK, Bazaka K. Plasma-activated water: generation, origin of ' 'reactive species and biological applications. J Phys D. ' '2020;53(30):303001.', 'journal-title': 'J Phys D'}, { 'key': '9886_CR12', 'doi-asserted-by': 'crossref', 'unstructured': 'Bisag A, Isabelli P, Laghi G, Laurita R, Dirani G, Taddei F, Bucci C, ' 'Capelli F, Gherardi M, Paglianti A et al. Cold atmospheric plasma ' 'decontamination of SARS-CoV‐2 bioaerosols. Plasma Process Polym. ' '2022;19(3).', 'DOI': '10.1002/ppap.202100133'}, { 'issue': '10', 'key': '9886_CR13', 'doi-asserted-by': 'publisher', 'first-page': '1396', 'DOI': '10.3390/covid2100100', 'volume': '2', 'author': 'C Loizou', 'year': '2022', 'unstructured': 'Loizou C, Kniazeva V, Apostolou T, Kornev A, Kostevitch S, Roslyakov E, ' 'Constantinou C, Hadjihannas L. Effect of cold atmospheric plasma on ' 'SARS-CoV-2 inactivation: a pilot study in the hospital environment. ' 'COVID. 2022;2(10):1396–404.', 'journal-title': 'COVID'}, { 'key': '9886_CR14', 'doi-asserted-by': 'crossref', 'unstructured': 'Bisag A, Isabelli P, Laurita R, Bucci C, Capelli F, Dirani G, Gherardi ' 'M, Laghi G, Paglianti A, Sambri V et al. Cold atmospheric plasma ' 'inactivation of aerosolized microdroplets containing bacteria and ' 'purified SARS-CoV‐2 RNA to contrast airborne indoor transmission. Plasma ' 'Process Polym. 2020;17(10).', 'DOI': '10.1002/ppap.202000154'}, { 'key': '9886_CR15', 'doi-asserted-by': 'publisher', 'first-page': '127742', 'DOI': '10.1016/j.cej.2020.127742', 'volume': '421', 'author': 'L Guo', 'year': '2021', 'unstructured': 'Guo L, Yao Z, Yang L, Zhang H, Qi Y, Gou L, Xi W, Liu D, Zhang L, Cheng ' 'Y, et al. Plasma-activated water: an alternative disinfectant for S ' 'protein inactivation to prevent SARS-CoV-2 infection. Chem Eng J. ' '2021;421:127742.', 'journal-title': 'CHEM ENG J'}, { 'issue': '4', 'key': '9886_CR16', 'doi-asserted-by': 'publisher', 'first-page': '44003', 'DOI': '10.1088/2058-6272/aa9842', 'volume': '20', 'author': 'D XU', 'year': '2018', 'unstructured': 'XU D, CUI Q, XU Y, WANG B, TIAN M, LI Q, LIU Z, LIU D, CHEN H, KONG MG. ' 'Systemic study on the safety of immuno-deficient nude mice treated by ' 'atmospheric plasma-activated water. Plasma Sci Technol. ' '2018;20(4):44003.', 'journal-title': 'Plasma Sci Technol'}, { 'issue': '21', 'key': '9886_CR17', 'doi-asserted-by': 'publisher', 'first-page': '11534', 'DOI': '10.3390/ijms222111534', 'volume': '22', 'author': 'V Nastasa', 'year': '2021', 'unstructured': 'Nastasa V, Pasca A, Malancus R, Bostanaru A, Ailincai L, Ursu E, Vasiliu ' 'A, Minea B, Hnatiuc E, Mares M. Toxicity assessment of long-term ' 'exposure to non-thermal plasma activated water in mice. Int J Mol Sci. ' '2021;22(21):11534.', 'journal-title': 'Int J Mol Sci'}, { 'issue': '4', 'key': '9886_CR18', 'doi-asserted-by': 'publisher', 'first-page': '204', 'DOI': '10.3390/plasma3040016', 'volume': '3', 'author': 'Y Hwang', 'year': '2020', 'unstructured': 'Hwang Y, Jeon H, Wang GY, Kim HK, Kim J, Ahn DK, Choi JS, Jang Y. Design ' 'and medical effects of a vaginal cleaning device generating ' 'plasma-activated water with antimicrobial activity on bacterial ' 'vaginosis. Plasma. 2020;3(4):204–13.', 'journal-title': 'Plasma'}, { 'issue': '2', 'key': '9886_CR19', 'first-page': '33', 'volume': '10', 'author': 'Y Jang', 'year': '2022', 'unstructured': 'Jang Y, Bok J, Ahn DK, Kim C, Kang J. Human trial for the effect of ' 'plasma-activated water spray on vaginal cleaning in patients with ' 'bacterial vaginosis. Med Sci. 2022;10(2):33.', 'journal-title': 'Med Sci'}, { 'key': '9886_CR20', 'doi-asserted-by': 'crossref', 'unstructured': 'Guo X, Lv X, Wu Y, Wang M, Wu S, Guo L, Wang Z, Shi Z, Huang R, Zhang H ' 'et al. Safety and efficacy of plasma-activated water on prolonged viral ' 'shedding of COVID‐19 patients: a randomized controlled trial. Plasma ' 'Process Polym. 2023.', 'DOI': '10.1002/ppap.202300195'}, { 'issue': '1', 'key': '9886_CR21', 'doi-asserted-by': 'publisher', 'first-page': '48', 'DOI': '10.1124/pharmrev.120.000108', 'volume': '74', 'author': 'S Anderson', 'year': '2022', 'unstructured': 'Anderson S, Atkins P, Bäckman P, Cipolla D, Clark A, Daviskas E, Disse ' 'B, Entcheva-Dimitrov P, Fuller R, Gonda I, et al. Inhaled medicines: ' 'past, present, and future. Pharmacol Rev. 2022;74(1):48–118.', 'journal-title': 'PHARMACOL REV'}, { 'key': '9886_CR22', 'doi-asserted-by': 'crossref', 'unstructured': 'Gül F, Gonen ZB, Jones OY, Taşlı NP, Zararsız G, Ünal E, Özdarendeli A, ' 'Şahin F, Eken A, Yılmaz S et al. A pilot study for treatment of severe ' 'COVID-19 pneumonia by aerosolized formulation of convalescent human ' 'immune plasma exosomes (ChipEXO™). Front Immunol. 2022;13.', 'DOI': '10.3389/fimmu.2022.963309'}, { 'issue': '8', 'key': '9886_CR23', 'doi-asserted-by': 'publisher', 'first-page': '1389', 'DOI': '10.1016/j.cell.2022.03.009', 'volume': '185', 'author': 'C Li', 'year': '2022', 'unstructured': 'Li C, Zhan W, Yang Z, Tu C, Hu G, Zhang X, Song W, Du S, Zhu Y, Huang K, ' 'et al. Broad neutralization of SARS-CoV-2 variants by an inhalable ' 'bispecific single-domain antibody. Cell. 2022;185(8):1389–401.', 'journal-title': 'Cell'}, { 'issue': '1', 'key': '9886_CR24', 'doi-asserted-by': 'publisher', 'first-page': '165', 'DOI': '10.1111/cts.13436', 'volume': '16', 'author': 'G Poulakou', 'year': '2023', 'unstructured': 'Poulakou G, Barakat M, Israel RJ, Bacci MR. Ribavirin aerosol in ' 'hospitalized adults with respiratory distress and COVID-19: an ' 'open‐label trial. Clin Transl Sci. 2023;16(1):165–74.', 'journal-title': 'Clin Transl Sci'}, { 'key': '9886_CR25', 'doi-asserted-by': 'publisher', 'first-page': '84', 'DOI': '10.1016/j.ijid.2020.07.053', 'volume': '99', 'author': 'F Zheng', 'year': '2020', 'unstructured': 'Zheng F, Zhou Y, Zhou Z, Ye F, Huang B, Huang Y, Ma J, Zuo Q, Tan X, Xie ' 'J, et al. SARS-CoV-2 clearance in COVID-19 patients with Novaferon ' 'treatment: a randomized, open-label, parallel-group trial. Int J Infect ' 'Dis. 2020;99:84–91.', 'journal-title': 'INT J INFECT DIS'}, { 'key': '9886_CR26', 'doi-asserted-by': 'crossref', 'unstructured': 'Cortázar OD, Megía-Macías A, Moreno S, Brun A, Gómez-Casado E. ' 'Vulnerability of SARS-CoV-2 and PR8 H1N1 virus to cold atmospheric ' 'plasma activated media. Sci Rep-UK. 2022;12(1).', 'DOI': '10.1038/s41598-021-04360-y'}, { 'issue': '2', 'key': '9886_CR27', 'doi-asserted-by': 'publisher', 'first-page': '123', 'DOI': '10.1016/j.jpha.2020.03.004', 'volume': '10', 'author': 'C Shen', 'year': '2020', 'unstructured': 'Shen C, Yu N, Cai S, Zhou J, Sheng J, Liu K, Zhou H, Guo Y, Niu G. ' 'Quantitative computed tomography analysis for stratifying the severity ' 'of Coronavirus disease 2019. J Pharm Anal. 2020;10(2):123–9.', 'journal-title': 'J PHARM ANAL'}, { 'key': '9886_CR28', 'unstructured': 'Assessing COVID-19-related symptoms in outpatient adult and adolescent ' 'subjects in clinical trials of drugs and biological products for ' 'COVID-19 prevention or treatment. ' 'https://www.fda.gov/media/142143/download. Accessed 13 August 2024.'}, { 'key': '9886_CR29', 'doi-asserted-by': 'crossref', 'unstructured': 'Azizmohammadi S, Azizmohammadi S, Dahmardeh S, Azargashb H, Shokouh SJH, ' 'Mohajeri-Iravani M, Mobasher M, Soleiman-Meigooni S, Zabihi M. Analysis ' 'of 239 ordinary and severe cases of COVID-19: clinical features and ' 'treatment. Eur J Transl Myol. 2021;31(3).', 'DOI': '10.4081/ejtm.2021.9579'}, { 'key': '9886_CR30', 'doi-asserted-by': 'crossref', 'unstructured': 'Li D, Liu C, Liu J, Hu J, Yang Y, Zhou Y. Analysis of risk factors for ' '24 patients with COVID-19 developing from moderate to severe condition. ' 'Front Cell Infect Mi. 2020;10.', 'DOI': '10.3389/fcimb.2020.548582'}, { 'issue': '8', 'key': '9886_CR31', 'doi-asserted-by': 'publisher', 'first-page': '4398', 'DOI': '10.1007/s00330-020-06816-7', 'volume': '30', 'author': 'Z Zhou', 'year': '2020', 'unstructured': 'Zhou Z, Guo D, Li C, Fang Z, Chen L, Yang R, Li X, Zeng W. Coronavirus ' 'disease 2019: initial chest CT findings. Eur Radiol. ' '2020;30(8):4398–406.', 'journal-title': 'EUR RADIOL'}, { 'key': '9886_CR32', 'doi-asserted-by': 'crossref', 'unstructured': 'Guo L, Xu R, Gou L, Liu Z, Zhao Y, Liu D, Zhang L, Chen H, Kong MG. ' 'Mechanism of virus inactivation by cold atmospheric-pressure plasma and ' 'plasma-activated water. Appl Environ Microb. 2018;84(17).', 'DOI': '10.1128/AEM.00726-18'}, { 'issue': '6', 'key': '9886_CR33', 'doi-asserted-by': 'publisher', 'first-page': '2811', 'DOI': '10.7150/thno.70098', 'volume': '12', 'author': 'P Wang', 'year': '2022', 'unstructured': 'Wang P, Zhou R, Zhou R, Li W, Weerasinghe J, Chen S, Rehm BHA, Zhao L, ' 'Frentiu FD, Zhang Z, et al. Cold atmospheric plasma for preventing ' 'infection of viruses that use ACE2 for entry. Theranostics. ' '2022;12(6):2811–32.', 'journal-title': 'THERANOSTICS'}, { 'issue': '15', 'key': '9886_CR34', 'doi-asserted-by': 'publisher', 'first-page': '9466', 'DOI': '10.1039/D2RA00009A', 'volume': '12', 'author': 'RR Khanikar', 'year': '2022', 'unstructured': 'Khanikar RR, Kalita M, Kalita P, Kashyap B, Das S, Khan MR, Bailung H, ' 'Sankaranarayanan K. Cold atmospheric pressure plasma for attenuation of ' 'SARS-CoV-2 spike protein binding to ACE2 protein and the RNA ' 'deactivation. Rsc Adv. 2022;12(15):9466–72.', 'journal-title': 'RSC ADV'}, { 'issue': '11', 'key': '9886_CR35', 'doi-asserted-by': 'publisher', 'first-page': 'e329', 'DOI': '10.1097/TP.0000000000003412', 'volume': '104', 'author': 'W Luo', 'year': '2020', 'unstructured': 'Luo W, Yu H, Gou J, Li X, Sun Y, Li J, He J, Liu L. Histopathologic ' 'findings in the explant lungs of a patient with COVID-19 treated with ' 'bilateral orthotopic lung transplant. Transplantation. ' '2020;104(11):e329–31.', 'journal-title': 'Transplantation'}, { 'issue': '4', 'key': '9886_CR36', 'doi-asserted-by': 'publisher', 'first-page': '420', 'DOI': '10.1016/S2213-2600(20)30076-X', 'volume': '8', 'author': 'Z Xu', 'year': '2020', 'unstructured': 'Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, ' 'Zhu L, et al. Pathological findings of COVID-19 associated with acute ' 'respiratory distress syndrome. Lancet Respiratory Med. 2020;8(4):420–2.', 'journal-title': 'Lancet Respiratory Med'}, { 'issue': '6', 'key': '9886_CR37', 'doi-asserted-by': 'publisher', 'first-page': '842', 'DOI': '10.1038/s41591-020-0901-9', 'volume': '26', 'author': 'M Liao', 'year': '2020', 'unstructured': 'Liao M, Liu Y, Yuan J, Wen Y, Xu G, Zhao J, Cheng L, Li J, Wang X, Wang ' 'F, et al. Single-cell landscape of bronchoalveolar immune cells in ' 'patients with COVID-19. Nat Med. 2020;26(6):842–4.', 'journal-title': 'NAT MED'}, { 'issue': '2', 'key': '9886_CR38', 'doi-asserted-by': 'publisher', 'first-page': '895', 'DOI': '10.1007/s40200-020-00577-2', 'volume': '19', 'author': 'MR Amini', 'year': '2020', 'unstructured': 'Amini MR, Sheikh Hosseini M, Fatollah S, Mirpour S, Ghoranneviss M, ' 'Larijani B, Mohajeri-Tehrani MR, Khorramizadeh MR. Beneficial effects of ' 'cold atmospheric plasma on inflammatory phase of diabetic foot ulcers; a ' 'randomized clinical trial. J Diabetes Metabolic Disorders. ' '2020;19(2):895–905.', 'journal-title': 'J Diabetes Metabolic Disorders'}, { 'issue': '1', 'key': '9886_CR39', 'doi-asserted-by': 'publisher', 'first-page': '15564', 'DOI': '10.1038/s41598-017-15725-7', 'volume': '7', 'author': 'YS Lee', 'year': '2017', 'unstructured': 'Lee YS, Lee M, Kim H, Won H, Kim C. Non-thermal atmospheric plasma ' 'ameliorates imiquimod-induced psoriasis-like skin inflammation in mice ' 'through inhibition of immune responses and up-regulation of PD-L1 ' 'expression. Sci Rep-UK. 2017;7(1):15564.', 'journal-title': 'SCI REP-UK'}, { 'issue': '7', 'key': '9886_CR40', 'doi-asserted-by': 'publisher', 'first-page': '1728', 'DOI': '10.1111/odi.13697', 'volume': '27', 'author': 'C Seebauer', 'year': '2021', 'unstructured': 'Seebauer C, Freund E, Hasse S, Miller V, Segebarth M, Lucas C, Kindler ' 'S, Dieke T, Metelmann HR, Daeschlein G, et al. Effects of cold physical ' 'plasma on oral lichen planus: an in vitro study (effects of CAP on OLP). ' 'Oral Dis. 2021;27(7):1728–37.', 'journal-title': 'ORAL DIS'}, { 'issue': '11', 'key': '9886_CR41', 'doi-asserted-by': 'publisher', 'first-page': '2710', 'DOI': '10.1016/j.jid.2021.04.019', 'volume': '141', 'author': 'S Zhai', 'year': '2021', 'unstructured': 'Zhai S, Xu M, Li Q, Guo K, Chen H, Kong MG, Xia Y. Successful treatment ' 'of vitiligo with cold atmospheric plasma–activated hydrogel. J Invest ' 'Dermatol. 2021;141(11):2710–9.', 'journal-title': 'J INVEST DERMATOL'}, { 'key': '9886_CR42', 'doi-asserted-by': 'crossref', 'unstructured': 'Zhang W, Chua B, Selva K, Kedzierski L, Ashhurst T, Haycroft E, Shoffner ' 'S, Hensen L, Boyd D, James F et al. Immune responses in COVID-19 ' 'respiratory tract and blood reveal mechanisms of disease severity. Res ' 'Sq. 2021.', 'DOI': '10.21203/rs.3.rs-802084/v1'}, { 'issue': '18', 'key': '9886_CR43', 'doi-asserted-by': 'publisher', 'first-page': '1708', 'DOI': '10.1056/NEJMoa2002032', 'volume': '382', 'author': 'W Guan', 'year': '2020', 'unstructured': 'Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, Liu L, Shan H, Lei C, Hui DSC, ' 'et al. Clinical characteristics of Coronavirus disease 2019 in China. ' 'New Engl J Med. 2020;382(18):1708–20.', 'journal-title': 'NEW ENGL J MED'}, { 'issue': '10223', 'key': '9886_CR44', 'doi-asserted-by': 'publisher', 'first-page': '497', 'DOI': '10.1016/S0140-6736(20)30183-5', 'volume': '395', 'author': 'C Huang', 'year': '2020', 'unstructured': 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, ' 'et al. Clinical features of patients infected with 2019 novel ' 'coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.', 'journal-title': 'Lancet'}, { 'issue': '1', 'key': '9886_CR45', 'doi-asserted-by': 'publisher', 'first-page': 'S138', 'DOI': '10.1378/chest.129.1_suppl.138S', 'volume': '129', 'author': 'SS Braman', 'year': '2006', 'unstructured': 'Braman SS. Postinfectious cough. Chest. 2006;129(1):S138–46.', 'journal-title': 'Chest'}, { 'issue': '5', 'key': '9886_CR46', 'doi-asserted-by': 'publisher', 'first-page': '533', 'DOI': '10.1016/S2213-2600(21)00125-9', 'volume': '9', 'author': 'W Song', 'year': '2021', 'unstructured': 'Song W, Hui CKM, Hull JH, Birring SS, McGarvey L, Mazzone SB, Chung KF. ' 'Confronting COVID-19-associated cough and the post-COVID syndrome: role ' 'of viral neurotropism, neuroinflammation, and neuroimmune responses. ' 'Lancet Respiratory Med. 2021;9(5):533–44.', 'journal-title': 'Lancet Respiratory Med'}, { 'key': '9886_CR47', 'doi-asserted-by': 'publisher', 'first-page': '40', 'DOI': '10.1016/j.imlet.2019.12.013', 'volume': '218', 'author': 'L Tamasauskiene', 'year': '2020', 'unstructured': 'Tamasauskiene L, Sitkauskiene B. Immune system in the pathogenesis of ' 'chronic cough. Immunol Lett. 2020;218:40–3.', 'journal-title': 'IMMUNOL LETT'}, { 'key': '9886_CR48', 'doi-asserted-by': 'crossref', 'unstructured': 'Lee M, Lee YS, Kim HJ, Han CH, Kang SU, Kim C. Non-thermal plasma ' 'inhibits mast cell activation and ameliorates allergic skin inflammatory ' 'diseases in NC/Nga mice. Sci Rep-UK. 2019;9(1).', 'DOI': '10.1038/s41598-019-49938-9'}, { 'key': '9886_CR49', 'doi-asserted-by': 'crossref', 'unstructured': 'Choi J, Song Y, Lee H, Hong J, Kim G. Inhibition of inflammatory ' 'reactions in 2,4-dinitrochlorobenzene induced Nc/Nga atopic dermatitis ' 'mice by non-thermal plasma. Sci Rep-UK. 2016;6(1).', 'DOI': '10.1038/srep27376'}], 'container-title': 'BMC Infectious Diseases', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1186/s12879-024-09886-w.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1186/s12879-024-09886-w/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1186/s12879-024-09886-w.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 9, 12]], 'date-time': '2024-09-12T09:05:33Z', 'timestamp': 1726131933000}, 'score': 1, 'resource': { 'primary': { 'URL': 'https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-024-09886-w'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 9, 12]]}, 'references-count': 49, 'journal-issue': {'issue': '1', 'published-online': {'date-parts': [[2024, 12]]}}, 'alternative-id': ['9886'], 'URL': 'http://dx.doi.org/10.1186/s12879-024-09886-w', 'relation': {}, 'ISSN': ['1471-2334'], 'subject': [], 'container-title-short': 'BMC Infect Dis', 'published': {'date-parts': [[2024, 9, 12]]}, 'assertion': [ { 'value': '12 April 2024', 'order': 1, 'name': 'received', 'label': 'Received', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '5 September 2024', 'order': 2, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '12 September 2024', 'order': 3, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, {'order': 1, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Declarations'}}, { 'value': 'The study was conducted according to the guidelines of the Declaration of ' 'Helsinki, and approved by the Medical Ethics Committee of the First Affiliated ' 'Hospital of the Air Force Medical University (Approval No.: KY20232004-C-1, ' 'January 5, 2023), registered with the Chinese Clinical Trial Registry ' '(Registration No.: ChiCTR2300078706). Informed consent was obtained from all ' 'subjects involved in the study.', 'order': 2, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Ethics approval and consent to participate'}}, { 'value': 'Not applicable.', 'order': 3, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Consent for publication'}}, { 'value': 'The authors declare no competing interests.', 'order': 4, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Competing interests'}}], 'article-number': '960'}